´ëÇѽÉÇ÷°üÁßÀçÇÐȸ ¿µ³²Áöȸ ÇÏ°èÁý´ãȸ : 2024-07-11
±³À°ÀÏÀÚ : 2024-07-11
±³À°Àå¼Ò : ¾Æ½ºÆ¼È£Åںλê 22Ãþ ±×·£µåº¼·ë
±³À°ÁÖÁ¦ : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ ¿µ³²Áöȸ ÇÏ°èÁý´ãȸ
ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¿µ³²Áöȸ
´ã´çÀÚ : ±èÁø¿Á
¿¬¶ôó : 051-711-6902
À̸ÞÀÏ : sericonf@gmail.com
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 70¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 2 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 10,000¿ø
ºñ°í ºñȸ¿ø( 10,000¿ø ), ȸ¿ø (¹«·á)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07¿ù 11ÀÏ ¾Æ½ºÆ¼È£Åںλê 22Ãþ ±×·£µåº¼·ë 18:30~18:50 Balloon Expandable TAVR(transcatheter aortic valve replacement) in women with small aortic annuli °¹Î±Ô(°æ»óÀÇ´ë)
±³À°½Ã°£ 07¿ù 11ÀÏ ¾Æ½ºÆ¼È£Åںλê 22Ãþ ±×·£µåº¼·ë 18:50~19:10 Acute Stent Thrombosis induced by Stent Elongation during PCI(percutaneous coronary intervention) ¹ÚÁ¾ÀÏ(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 07¿ù 11ÀÏ ¾Æ½ºÆ¼È£Åںλê 22Ãþ ±×·£µåº¼·ë 19:10~19:30 Gaia Next 4 for a heavily calcified CTO(chronic total occlusion) PCI(percutaneous coronary intervention) ±èÈ«³â(°æºÏÀÇ´ë)
±³À°½Ã°£ 07¿ù 11ÀÏ ¾Æ½ºÆ¼È£Åںλê 22Ãþ ±×·£µåº¼·ë 19:30~19:50 Update of Escalation Strategy for Cardiogenic Shock ±è¹Îö(Àü³²ÀÇ´ë)
Åä·Ð 07¿ù 11ÀÏ ¾Æ½ºÆ¼È£Åںλê 22Ãþ ±×·£µåº¼·ë 19:50~20:10 Discussion ()
±³À°½Ã°£ 07¿ù 11ÀÏ ¾Æ½ºÆ¼È£Åںλê 22Ãþ ±×·£µåº¼·ë 20:10~20:30 Valve-in-valve transcatheter aortic valve replacement (ViV TAVR) ÀÌÁø¹è(´ë±¸°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 07¿ù 11ÀÏ ¾Æ½ºÆ¼È£Åںλê 22Ãþ ±×·£µåº¼·ë 20:30~20:50 Factors to Consider in Patients with Inadequate Response to Statin therapy Àå¹ÌÈñ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 07¿ù 11ÀÏ ¾Æ½ºÆ¼È£Åںλê 22Ãþ ±×·£µåº¼·ë 20:50~21:10 Stories that happen with ECMO(extracorporeal membrane oxygenation) ÀÌöÇö(°è¸íÀÇ´ë)